ATG5 and hepatocellular carcinoma: In an oxaliplatin resistance experiment of liver cancer cells, after the co-culture of TAMs and hepatocellular carcinoma (HCC) cells, it was reported that HCC autophagy was activated, HCC was resistant to oxaliplatin, and the sensitivity of HCC cells to oxaliplatin was significantly enhanced when ATG5 siRNA was applied to inhibit autophagy of HCC cells.